Literature DB >> 6796737

A comparison of the differential effects of nitroglycerin, nifedipine and papaverine on contractures induced in vascular and intestinal smooth muscle by potassium and lanthanum.

S Imai, T Kitagawa.   

Abstract

To elucidate the mechanisms of smooth muscle relaxant effects of nitroglycerin, the effects of this substance on the potassium contracture (K+-contracture) and the lanthanum-induced contracture (La3+-contracture) were studied using smooth muscle preparations of the canine coronary artery and colon and the findings compared with the effects of nifedipine, a representative calcium antagonistic vasodilator. The effects of papaverine, a prototype smooth muscle relaxant, were also studied. La3+-contracture was induced in a calcium-free environment with the addition of lanthanum, an effective blocker of calcium influx. In the coronary artery, nitroglycerin produced a relaxation both of the La3+-contracture not K-contracture in the colon was affected. Nifedipine did not relax the La3+-contracture in a range of doses at which K+-contracture of both types of smooth muscles was relaxed. Papaverine produced a relaxation of La3+-contracture as well as K+-contracture, in both types of smooth muscles. Unlike the mechanism related to the relaxant effects of nifedipine, which is generally admitted to be an inhibition of calcium influx, the relaxant effect of nitroglycerin was attribute to the suppression of calcium release from the intracellular store sites and/or stimulation of calcium uptake into the intracellular store-sites. Papaverine was assumed to produce a relaxation through augmentation of the calcium binding to the intercellular store sites for calcium as well as through inhibition of the calcium influx.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796737     DOI: 10.1254/jjp.31.193

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  8 in total

1.  Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons.

Authors:  L G Svensson; C M Von Ritter; H T Groeneveld; E S Rickards; S J Hunter; M F Robinson; R A Hinder
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

2.  Front-surface fluorometry with fura-2 and effects of nitroglycerin on cytosolic calcium concentrations and on tension in the coronary artery of the pig.

Authors:  S Abe; H Kanaide; M Nakamura
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  Cholesterol-Induced Suppression of Endothelial Kir Channels Is a Driver of Impairment of Arteriolar Flow-Induced Vasodilation in Humans.

Authors:  Sang Joon Ahn; Ibra S Fancher; Sara T Granados; Natalia F Do Couto; Chueh-Lung Hwang; Shane A Phillips; Irena Levitan
Journal:  Hypertension       Date:  2021-11-17       Impact factor: 10.190

4.  Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2.

Authors:  T Yanagisawa; M Kawada; N Taira
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Mechanisms of the nitroglycerine-induced vasodilation in vascular smooth muscles of the rabbit and pig.

Authors:  T Itoh; H Kuriyama; H Ueno
Journal:  J Physiol       Date:  1983-10       Impact factor: 5.182

6.  Role of intracellular Ca2+ and the calmodulin messenger system in pepsinogen secretion from isolated rabbit gastric mucosa.

Authors:  T Miyamoto; M Itoh; Y Noguchi; K Yokochi
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

7.  Differential vasodilator properties of KRN2391, cromakalim, nitroglycerin and nifedipine in rabbit isolated femoral artery and vein.

Authors:  T Kashiwabara; N Ogawa; T Izawa; H Fukushima
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

8.  Ketamine-inhibition of calcium-induced contractions in depolarized rat uterus: a comparison with other calcium antagonists.

Authors:  J B Calixto; S Loch
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.